April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Color Doppler Imaging Of The Superior Ophthalmic Vein In Patients With Graves’ Orbitopathy Before And After Treatment Of Congestive Disease
Author Affiliations & Notes
  • Mario L. Monteiro
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • Hélio Angotti-Neto
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • Rodrigo Moritz
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • Joseph E. Benabou
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  Mario L. Monteiro, None; Hélio Angotti-Neto, None; Rodrigo Moritz, None; Joseph E. Benabou, None
  • Footnotes
    Support  CNPq
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mario L. Monteiro, Hélio Angotti-Neto, Rodrigo Moritz, Joseph E. Benabou; Color Doppler Imaging Of The Superior Ophthalmic Vein In Patients With Graves’ Orbitopathy Before And After Treatment Of Congestive Disease. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5110.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare color Doppler imaging (CDI) parameters of the superior ophthalmic vein (SOV) in patients with Congestive Graves’ orbitopathy (GO) before and after treatment (orbital decompression and/or corticosteroids) of the orbitopathy.

Methods: : Twenty two orbits of 12 patients with congestive phase of Graves' Orbitopathy were evaluated using CDI of the superior ophthalmic vein before and 6 months or later after treatment of the congestive orbitopathy. Twelve orbits were from patients with dysthyroid optic neuropathy. Treatment consisted of orbital decompression in 16 orbits and corticosteroids in 6 orbits. The findings before and after treatment were compared.

Results: : In the congestive disease SOV flow was detected and anteroposterior in 14, detected and reverse in 4 and undetectable in 5. After treatment SOV flow was detected and anteroposterior in 19 and undetected in 1 orbit (p<0.05). Comparison of SOV flow parameters revealed a significant difference between the groups regarding maximum SOV flow velocity. SOV flow was significantly reduced in the congestive phase compared to SOV flow parameters after treatment.

Conclusions: : SOV is significantly reduced in orbits with congestive GO when compared to normals. SOV reduction is significantly improved after treatment of the acute orbitopathy. SOV congestion may be a contributing pathogenic factor in the both congestive phase of Grave's bitopathy.

Clinical Trial: : http://www.clinicaltrials.gov NCT00697528

Keywords: orbit • optic flow • clinical research methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×